Referrals
search
eNewsletter HealthPoints Sign up for our HealthPoints E-Newsletter
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
Surgical Science
Cancer & Tumor Biology
Cardiovascular Disease
Diabetes Complications
immunity & Inflammation
Neurodegenerative Diseases
Featured Researcher
Grants
Previous Research
Equipment Calendar
What's New
Staff
Contact Us

Research
Previous Research


Unusual RAGE protein worsens rheumatoid arthritis

Why does rheumatoid arthritis cripple some while others are only mildly affected? New research from a Columbia University Health Sciences researcher reveals that a certain form of a gene called RAGE is more common in people with rheumatoid arthritis.

RAGE (the receptor for advanced glycation end products) is a protein found on cell surfaces in joints. The binding of RAGE to other proteins called S100/calgranulins leads to inflammation and ultimately joint destruction. In a study, led by Dr. Ann Marie Schmidt, Chief, Division of Surgical Science in the Department of Surgery, the researchers found that the protein product from a certain form of the RAGE gene bound more avidly to S100/calgranulins and increased activity of molecules that led to joint destruction. When RAGE was prevented from binding to the S100/calgranulins arthritic mice had decreased joint inflammation. The findings, published in the May Genes and Immunity, suggest new types of rheumatoid arthritis treatments against RAGE proteins could be developed.


     Contact Us About Us  Ways to Give Site Map Disclaimer Find a Physician Patient Forms Intranet
Columbia University Medical Center NewYork-Presbyterian Hospital